These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients. Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121 [TBL] [Abstract][Full Text] [Related]
10. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241 [TBL] [Abstract][Full Text] [Related]
12. Trends in erythropoietin therapy in the U.S. dialysis population: 1995 to 1998. Kimmel PL; Greer JW; Milam RA; Thamer M Semin Nephrol; 2000 Jul; 20(4):335-44. PubMed ID: 10928335 [TBL] [Abstract][Full Text] [Related]
13. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia? Deaver K; Bennington L Nephrol Nurs J; 2006; 33(4):430-7; quiz 438. PubMed ID: 17002001 [TBL] [Abstract][Full Text] [Related]
14. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial. Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis. Berns JS; Mosenkis A Hemodial Int; 2005 Jan; 9(1):7-22. PubMed ID: 16191049 [TBL] [Abstract][Full Text] [Related]
16. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients? Dukkipati R; Kalantar-Zadeh K Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263 [TBL] [Abstract][Full Text] [Related]
17. Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment. Fishbane S; Kalantar-Zadeh K; Nissenson AR Semin Dial; 2004; 17(5):336-41. PubMed ID: 15461737 [TBL] [Abstract][Full Text] [Related]
18. Timely correction of anemia at the initiation of dialysis. Case study of the anemic patient. Breiterman-White R Nephrol Nurs J; 2002 Oct; 29(5):469-72. PubMed ID: 12434453 [TBL] [Abstract][Full Text] [Related]
19. Epoetin omega for treatment of anemia in maintenance hemodialysis patients. Sikole A; Spasovski G; Zafirov D; Polenakovic M Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756 [TBL] [Abstract][Full Text] [Related]
20. Anemia of chronic renal failure: new treatment alternative. Seiler S CANNT J; 2000; 10(3):35-9, 43-8; quiz 40-2, 49-51. PubMed ID: 11799582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]